Literature DB >> 15356461

Clinicopathologic conference: trismus following dental treatment.

Hugo St -Hilaire1, William D Weber, Marie Ramer, Harry Lumerman.   

Abstract

Myositis ossificans traumatica is a rare clinical entity in the maxillofacial region. We present a case of myositis ossificans traumatica of the temporalis muscle following dental treatment in the form of a clinicopathologic conference. A review of the literature supporting our findings is provided.

Entities:  

Mesh：

Year:  2004        PMID： 15356461     DOI： 10.1016/S1079210404001593

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN： 1079-2104


  5 in total

1.  Pseudomalignant myositis ossificans involving multiple masticatory muscles: Imaging evaluation.

Authors:  Muralidhar G Kamalapur; Pritam B Patil; Shyamsundar Joshi; Dinesh Shastri
Journal:  Indian J Radiol Imaging       Date:  2014-01

2.  Operative management of idiophatic myositis ossificans of lateral pterygoid muscle.

Authors:  Luis Eduardo Almeida; Andrea Doetzer; Flavio Camejo; Jose Bosio
Journal:  Int J Surg Case Rep       Date:  2014-09-16

3.  Post-infectious myositis ossificans in medial, lateral pterygoid muscles: A case report and review of the literature.

Authors:  Qian Jiang; Min-Jie Chen; Chi Yang; Ya-Ting Qiu; Zhen Tian; Zhi-Yuan Zhang; Wei-Liu Qiu
Journal:  Oncol Lett       Date:  2014-11-19       Impact factor: 2.967

4.  Myositis Ossificans Traumatica of the Temporal Muscle: a Case Report and Literature Review Emphasizing Radiographic Features on Computed Tomography and Magnetic Resonance Imaging.

Authors:  Erika Antonia Dos Anjos Ramos; Luciana Munhoz; Basílio Almeida Milani; Fernando Pando de Matos; Emiko Saito Arita
Journal:  J Oral Maxillofac Res       Date:  2019-12-30

Review 5.  Myositis ossificans traumatica of the masticatory muscles: etiology, diagnosis and treatment.

Authors:  Marcel Hanisch; Lale Hanisch; Leopold F Fröhlich; Richard Werkmeister; Lauren Bohner; Johannes Kleinheinz
Journal:  Head Face Med       Date:  2018-10-29       Impact factor: 2.151
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.